Valuation: Olympus Corporation

Market Cap 2,135B 13.55B 12.04B 11.26B 10.26B 19.31B 1,305B 19.58B 136B 52.72B 665B 50.89B 49.79B P/E 2027 *
20.5x
P/E 2028 * 17.6x
Enterprise Value 2,219B 14.09B 12.51B 11.7B 10.66B 20.07B 1,356B 20.35B 142B 54.8B 691B 52.89B 51.74B EV / Sales 2027 *
2.05x
EV / Sales 2028 * 1.96x
Free-Float
94.58%
Yield 2027 *
1.53%
Yield 2028 * 1.59%
1 day-0.55%
1 week+0.56%
Current month-0.55%
1 month-4.98%
3 months+25.12%
6 months+27.53%
Current year-0.55%
1 week 12.57
Extreme 12.57
13.04
1 month 12.19
Extreme 12.19
13.27
Current year 8.08
Extreme 8.08
13.72
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 64 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Director/Board Member 59 2021-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-0.55%+0.56% - - 13.55B
-3.34%-3.81%+22.95%+28.91% 241B
-4.42%-5.37%-0.53%-14.65% 149B
-1.33%+0.43%-8.40%+37.27% 142B
-0.96%-3.25%-54.90%-18.12% 62.65B
-1.31%-0.63%+11.64%+22.96% 49.1B
-3.27%-3.56%+20.28%+49.06% 46.99B
+0.55%-0.19%-19.59%-21.53% 47.13B
-1.23%+2.58%-3.86%+38.57% 45.65B
-3.15%-1.11%+33.06%+55.18% 41.81B
Average -1.90%+0.29%+0.07%+19.74% 91.69B
Weighted average by Cap. -2.50%+0.45%+3.19%+18.70%

Financials

2027 *2028 *
Net sales 1,082B 6.87B 6.1B 5.71B 5.2B 9.79B 662B 9.93B 69.05B 26.73B 337B 25.8B 25.24B 1,123B 7.13B 6.33B 5.92B 5.4B 10.16B 686B 10.3B 71.64B 27.73B 350B 26.77B 26.19B
Net income 105B 670M 595M 556M 507M 954M 64.49B 968M 6.73B 2.61B 32.84B 2.51B 2.46B 122B 773M 687M 642M 585M 1.1B 74.44B 1.12B 7.77B 3.01B 37.91B 2.9B 2.84B
Net Debt 83.87B 533M 473M 442M 403M 759M 51.27B 769M 5.35B 2.07B 26.11B 2B 1.96B 65.49B 416M 369M 345M 315M 593M 40.04B 601M 4.18B 1.62B 20.39B 1.56B 1.53B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-10-01 US$12.60 -0.55% 34,545
26-09-30 US$12.67 -2.84% 94,657
26-09-29 US$13.04 +1.80% 30,301
26-09-28 US$12.81 -0.54% 38,706
26-09-25 US$12.88 +2.79% 45,314
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,008.50JPY
Average target price
2,184.62JPY
Spread / Average Target
+8.77%

Quarterly revenue - Rate of surprise